Aurora SFC Closes Venture Capital Round
Aurora SFC Systems announced that it has successfully closed a Series B venture capital financing.
Aurora SFC Systems announced that it has successfully closed a Series B venture capital financing. The round was led by Aphelion Capital with participation from California Technology Partners, the Arbor Group, and several prominent Silicon Valley investors. The new capital will be used to accelerate the company’s growth in all segments of the business with a particular focus on market and product development.
Aurora SFC was founded in 2007 by Dr. Terry Berger. This new funding continues the upward trajectory of Aurora SFC that was highlighted by the announcement at Pittcon 2010 of an OEM agreement that allows Agilent Technologies to incorporate Aurora’s SFC Fusion A5 instrument into a new Agilent SFC system.
“This investment marks a significant milestone for Aurora SFC Systems and is a strong endorsement of our strategy and execution. We are proud of our technology innovations, our partnership with Agilent, and we greatly appreciate the growing acceptance of our analytical SFC products by our loyal customers” said Dr. Berger, Founder and Chief Science Office. “We are pleased to have the support of this stellar investment group, given their strong track record and deep experience in working with emerging growth companies to achieve success.”
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
